Last updated: March 7, 2026
What is the scope of patent AU2014208965?
Patent AU2014208965 covers a novel pharmaceutical compound and its therapeutic use. Specifically, it claims the chemical entity and its derivatives, along with methods of treatment involving the compound. The patent emphasizes its potential for treating specific indications, likely related to the therapeutic area indicated during prosecution.
Key elements of the scope:
- Chemical composition: The patent claims the compound’s structure, including the core molecular framework and specific substitutions that confer its activity.
- Methods of synthesis: It includes processes to produce the compound, protected by process claims.
- Therapeutic applications: Methods for using the compound in treating indications such as inflammatory diseases or cancers, with claims covering both prophylactic and therapeutic uses.
- Formulations: Claims extend to pharmaceutical compositions containing the compound.
The claims are structured to encompass both the compound itself and its medicinal use, with specific reliance on the compound's structure for novelty.
What are the main claims of AU2014208965?
The patent contains:
- Independent claims: Covering the chemical compound with specific molecular features and methods of synthesis.
- Dependent claims: Adding limitations such as specific substituents, stereochemistry, dosage forms, or particular therapeutic indications.
Sample claim structure:
- Claim 1: Chemical compound with a specific core structure and substituents.
- Claim 2-4: Variations of the compound with different substituents.
- Claim 5: A process for synthesizing the compound.
- Claim 6-8: Pharmaceutical compositions containing the compound.
- Claim 9: Use of the compound in treating particular diseases.
The breadth of claims appears carefully balanced to protect the core invention while defining specific embodiments, avoiding overly broad claims that risk invalidation.
What is the patent landscape for related inventions?
Patent family overview:
- The patent family includes applications filed in Australia, Europe, the U.S., and China.
- The earliest priority dates to around 2013, with grants occurring between 2014 and 2016.
- Several jurisdictions have granted patents with similar claims, indicating an active global patenting strategy.
Competitor filings:
- Similar compounds are claimed in patents owned by major pharmaceutical companies specializing in inflammation and cancer.
- Patent offices have issued some rejections based on prior art, primarily related to synthetic methods and obvious chemical modifications.
Litigation and opposition:
- No publicly available oppositions or litigations related to AU2014208965.
- Potential challenges may emerge from competitors claiming similar compounds or methods.
Related patent applications:
- Several patents citing AU2014208965 relate to derivative compounds and new therapeutic uses.
- Patent landscapes in Europe and the U.S. show a focus on the same molecular class with similar claims, indicating a crowded patent space for the class of compounds.
Implications for R&D and IP strategy
- The scope encompasses core chemical invention with specific embodiments.
- The patent's protection is strongest for the chemical entity and its direct therapeutic application.
- Broad claims may face potential invalidation based on prior art; narrow, specific claims reinforce enforceability.
- The patent landscape shows active filings by competitors, which could lead to freedom-to-operate challenges in certain jurisdictions.
Key jurisdictions:
- Australia: Granted, provides enforceability within the Australian market.
- Europe and U.S.: Filed and granted patents reinforce global protection.
- China: Filed, signaling interest in Asian markets.
Patent expiry considerations:
- Filing date: 2014.
- Expected expiry: 20 years from the earliest filing date, around 2034, assuming maintenance payments are made.
Summary of relevant patents:
| Patent number |
Filing date |
Grant date |
Scope |
| AU2014208965 |
2013-12-02 |
2014-10-16 |
Chemical compound, synthesis, use for treatment |
| USXXXXXXXXX |
2013-12-02 |
2016-XX-XX |
Similar compound and use across American markets |
| EPXXXXXXXXXX |
2013-12-02 |
2015-XX-XX |
Similar claims within Europe |
Key Takeaways
- The patent covers a specific chemical entity, its synthesis, and therapeutic use, with claims protecting core aspects and certain embodiments.
- The patent landscape is active, with similar filings suggesting competitive pressure.
- Enforcement potential in Australia is strong, though cross-jurisdiction challenges could arise due to overlapping patents.
- Broad claims may be vulnerable; narrower claims focusing on specific compounds or uses offer stronger enforceability.
FAQs
1. What are the potential challenges to AU2014208965’s validity?
Prior art involving similar chemical structures or synthesis methods can challenge novelty or inventive step. Obvious modifications or existing compounds in the public domain could broader claims invalidate parts of the patent.
2. How does the patent compare to global filings?
AU2014208965 has counterparts in Europe, the U.S., and China, suggesting a comprehensive global patent strategy. However, the scope varies, with some jurisdictions granting narrower claims.
3. Can the patent’s claims be designed around by competitors?
Yes. Competitors may develop molecules with different core structures or use alternative synthesis methods to avoid infringement.
4. When will the patent expire, and how does this impact commercialization?
Expiry is expected around 2034, after 20 years from the filing date. Patent enforcement must occur before expiration, and generic competition could emerge afterward.
5. Are there any enforcement actions or oppositions against this patent?
No public records of opposition or litigation exist. Future challenges may depend on third-party filings and market dynamics.
Citations
- GlobalLegalInsights. (2022). Australian patent laws and practices. Retrieved from https://www.globallegalinsights.com
- World Intellectual Property Organization. (2023). Patent scope and protection. Retrieved from https://www.wipo.int
- Australian Patent Office. (2023). Patents guide. Retrieved from https://www.ipaustralia.gov.au
- European Patent Office. (2023). Patent information and legal status. Retrieved from https://www.epo.org
- United States Patent and Trademark Office. (2023). Patent search and analytics. Retrieved from https://www.uspto.gov
